Postnatal Glucocorticoids in Very Preterm Infants: “The Good, the Bad, and the Ugly”?

This publication has 22 references indexed in Scilit:

• Early postnatal dexamethasone treatment and increased incidence of cerebral palsy
  Archives of Disease in Childhood: Fetal & Neonatal, 2000
• Methylprednisolone, an alternative to dexamethasone in very premature infants at risk of chronic lung disease
  Intensive Care Medicine, 2000
• Therapeutic implications of non-genomic glucocorticoid activity
  The Lancet, 2000
• Neurodevelopmental and Functional Outcomes of Extremely Low Birth Weight Infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993–1994
  Pediatrics, 2000
• Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants
  New England Journal of Medicine, 1999
• Randomized Placebo-controlled Trial of a 42-Day Tapering Course of Dexamethasone to Reduce the Duration of Ventilator Dependency in Very Low Birth Weight Infants: Outcome of Study Participants at 1-Year Adjusted Age
  Pediatrics, 1999
• Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease
  Pediatric Research, 1999
• CONTROLLED TRIAL OF DEXAMETHASONE THERAPY IN INFANTS WITH BRONCHOPULMONARY DYSPLASIA
  The Lancet, 1983
• Reductions in size and total DNA of cerebrum and cerebellum in adult mice after corticosterone treatment in infancy
  Experimental Neurology, 1968
• Pulmonary Disease Following Respirator Therapy of Hyaline-Membrane Disease
  New England Journal of Medicine, 1967